267 related articles for article (PubMed ID: 18154745)
1. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update.
Selwyn AP
Am J Cardiol; 2007 Dec; 100(12A):33P-37P. PubMed ID: 18154745
[TBL] [Abstract][Full Text] [Related]
2. Challenges and strategies in managing cardiometabolic risk.
Repas TB
J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
[TBL] [Abstract][Full Text] [Related]
3. Unmet needs in controlling metabolic disease.
Haffner SM
Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
[TBL] [Abstract][Full Text] [Related]
4. Optimal diabetes management during medical weight loss for cardiovascular risk reduction.
Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284
[TBL] [Abstract][Full Text] [Related]
5. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
[TBL] [Abstract][Full Text] [Related]
6. Addressing the unmet medical need for safe and effective weight loss therapies.
Arbeeny CM
Obes Res; 2004 Aug; 12(8):1191-6. PubMed ID: 15340099
[TBL] [Abstract][Full Text] [Related]
7. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
Bays H; Blonde L; Rosenson R
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):871-95. PubMed ID: 17173503
[TBL] [Abstract][Full Text] [Related]
8. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).
; Leiter LA; Fitchett DH; Gilbert RE; Gupta M; Mancini GB; McFarlane PA; Ross R; Teoh H; Verma S; Anand S; Camelon K; Chow CM; Cox JL; Després JP; Genest J; Harris SB; Lau DC; Lewanczuk R; Liu PP; Lonn EM; McPherson R; Poirier P; Qaadri S; Rabasa-Lhoret R; Rabkin SW; Sharma AM; Steele AW; Stone JA; Tardif JC; Tobe S; Ur E
Can J Cardiol; 2011; 27(2):124-31. PubMed ID: 21459258
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now?
Sattar N
Minerva Endocrinol; 2005 Sep; 30(3):121-38. PubMed ID: 16208304
[TBL] [Abstract][Full Text] [Related]
10. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
Ballantyne CM
Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
[TBL] [Abstract][Full Text] [Related]
11. Weight management in type 2 diabetes mellitus.
Siram AT; Yanagisawa R; Skamagas M
Mt Sinai J Med; 2010; 77(5):533-48. PubMed ID: 20960555
[TBL] [Abstract][Full Text] [Related]
12. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
Després JP
Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261
[No Abstract] [Full Text] [Related]
13. Cardiovascular risk and cardiometabolic protection: role of glitazones.
Petrazzi L; Grassi D; Polidoro L; D'Aurelio A; Croce G; Properzi G; Tiberti S; Desideri G; Ferri C
J Nephrol; 2008; 21(6):826-35. PubMed ID: 19034866
[TBL] [Abstract][Full Text] [Related]
14. Obesity and lifestyle management in polycystic ovary syndrome.
Hoeger KM
Clin Obstet Gynecol; 2007 Mar; 50(1):277-94. PubMed ID: 17304042
[TBL] [Abstract][Full Text] [Related]
15. The metabolic syndrome: definitions, prevalence and management.
Levesque J; Lamarche B
J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle modifications for the prevention and treatment of cardiovascular disease: an evidence-based approach.
Harris GD; White RD
Mo Med; 2004; 101(3):222-6. PubMed ID: 15311577
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction.
Andreassi MG
Mutat Res; 2009 Jul; 667(1-2):35-43. PubMed ID: 19028510
[TBL] [Abstract][Full Text] [Related]
18. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
Nathan BM; Moran A
Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
[TBL] [Abstract][Full Text] [Related]
19. Obesity: a main factor of metabolic syndrome?
Licata G; Argano C; Di Chiara T; Parrinello G; Scaglione R
Panminerva Med; 2006 Jun; 48(2):77-85. PubMed ID: 16953145
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and obesity: new data on mechanisms and intervention trials.
Nilsson PM
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):243-7. PubMed ID: 15853598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
